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Epstein-Barr virus (EBV) DNase possesses both endonuclease and exonuclease activities and accepts both double-
stranded DNA (dsDNA) and single-stranded DNA (ssDNA) as substrates. To map regions of EBV DNase responsible for
nuclease and DNA binding activities, a series of mutant DNase polypeptides was expressed using a bacterial system for the
nuclease assay and in an in vitro transcription/translation system to assay binding activity to dsDNA or ssDNA cellulose. The
results indicated that the C-terminus of EBV DNase, residues 450–460, is essential for nuclease activity but dispensable for
DNA binding. However, deletion of residues 441–470 resulted in the loss of both nuclease and DNA binding activities.
Substitution of Phe452 and Val458 led to inactive enzymes. In the N-terminus, deletion of residues 23–28 and residues 7–61
resulted in the loss of nuclease activity but the DNA binding activities of the deleted enzymes were intermediate and low,
respectively. Mutation of Leu23 to Gly showed drastically reduced nuclease activity but its DNA binding ability was not
affected. Based on the amino acid sequence alignment of various herpesvirus DNases, we chose four highly conserved and
two less well conserved regions as controls for mutagenesis studies. These six internal deletion (ID) mutants were prepared
using a recombinant PCR method. Each of the polypeptides was expressed in a bacterial system for the nuclease assay and
using an in vitro transcription/translation system for the DNA binding assay. DNA binding and nuclease activities of all six
internal deletion mutants were abolished, except that mutant ID2, with deletion of residues 138–152, retained an intermediate
ability to bind DNA. These data indicate that since mutations at distinct regions within EBV DNase resulted in the loss of
nuclease and/or DNA binding activities, it is suggested that these distinct regions are required for maintenance of an intact
and highly ordered structure(s) for both activities. © 1998 Academic Press
INTRODUCTION
Epstein-Barr virus (EBV), a member of the herpesviri-
dae, is the etiological agent of infectious mononucleosis
(IM) (Henle et al., 1968) and is associated with several
cancers, including Burkitt’s lymphoma (BL) (Epstein et al.,
1964), nasopharyngeal carcinoma (NPC) (Henle et al.,
1970), oral hairy leukoplakia (Greenspan et al., 1985),
X-linked lymphoproliferative disease (Purtilo et al., 1982),
T cell lymphoma (Su et al., 1991), and Hodgkin’s disease
(Weiss et al., 1989). EBV infection generally is latent in B
cells and causes those cells to proliferate continuously.
The latent state in infected B cells can be disrupted by
treatment with agents such as 12-O-tetradecanoylphor-
bol-13-acetate (TPA), cross-linking of surface immuno-
globulin, or superinfection. After EBV activation, lytic pro-
teins including immediate early antigens (IE), early anti-
gens (EA), virus capsid antigens (VCA), and membrane
antigens (MA) are expressed in sequence and infectious
virus can be produced.
In common with herpesviruses, EBV produces a spe-
cific deoxyribonuclease (DNase) activity detectable early
in the lytic cycle which has been shown to have both
endonuclease and exonuclease activities. DNase also
has a strong requirement for divalent cations and an
alkaline pH for optimal activity (Clough, 1979, 1980).
DNase activity was also found in superinfected Raji cells
and in chemically treated D98/HR-1 cells (Cheng et al.,
1980b). DNase activity could be neutralized by sera from
patients with NPC. Patients with NPC have higher levels
of antibody against EBV DNase than normal controls and
their antibody levels may be raised prior to the appear-
ance of clinical symptoms of NPC (Cheng et al., 1980a;
Chen et al., 1985a,b, 1989). Therefore, antibody against
EBV DNase may be useful as a marker for the early
detection of patients with NPC. We have reported that
recombinant EBV DNase proteins, expressed using the
pET plasmid expression system, can be purified and
used as the antigen in a dot immunobinding assay and
ELISA to detect specific antibodies in the sera of NPC
patients (Chen et al., 1993). The purified recombinant
DNase also was used as the source for biochemical
characterization of enzyme activity. Those properties, in-
cluding the requirement for divalent cations, optimum
pH, and inhibitory concentrations of ionic strength and
polyamines, were very similar between bacterially ex-
pressed DNase and that purified from EBV producing
lymphoblastoid cells (Chen et al., 1993). Other properties
were characterized further and the results indicated that
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the final products of EBV DNase digestion are 59-mono-
phosphate nucleosides. EBV DNase acted processively
on dsDNA but distributively on ssDNA and the EBV major
DNA binding protein (mDBP), but not EA-D, was shown
to inhibit EBV DNase activity (Lin et al., 1995).
In a previous study, we tried to locate the regions impor-
tant for DNase activity by serially deleting amino acid res-
idues from both ends of the recombinant DNase; a drastic
loss of DNase activity was observed in mutants with small
deletions and point mutations (Lin et al., 1994). In this study,
we have extended this mutational analysis to C-terminal
and internal regions and located those that are involved in
nuclease activity. These mutant DNase polypeptides also
were expressed using an in vitro transcription/translation
(IVT) system and assayed for DNA binding activity using
dsDNA and ssDNA cellulose columns.
RESULTS
Deletion and point mutations of carboxyl terminus
In our previous study, deletion of residues 23–28 of
EBV DNase resulted in the loss of nuclease activity.
Furthermore, substitution of Gly for Leu at residue 23
showed a drastic reduction of nuclease activity. Mutants
with large fragment deletions at the C-terminus did not
produce detectable nuclease activities (Lin et al., 1994).
To determine the role of the C-terminus of EBV DNase,
we constructed two mutants with codons 460 or 450
changed to a stop codon (TAG) (Table 1). Bacterially
expressed proteins of these two mutants and wild-type
were detected by ECL Western blotting and the relative
activities of the two mutants to wild-type are shown in
Fig. 1. CD460, with the C-terminal 11 residues deleted,
TABLE 1
Oligonucleotides Primers Used for Mutagenesis




antisense Uses (for the construction of ..)
C3 taaactcctcatagt - (on pET3a) Antisense For CD, M451-460 sequencing
CDP450 GGTGTCAAAAGTctaGTCTGCGTACGC 1336..1362 Antisense Introducing TAG at aa 450
CDP460 GGCAAAGAGACCctaGGGCACCCATGG 1366..1392 Antisense Introducing TAG at aa 460
T7 taatacgactcactataggg - (on pET3a) Sense M452-60, 59, outside primer
MP451 CGCGGTGTCAAAtgcGTCGTCTGCGTA 1339..1365 Antisense M451
MP452a TGGCGCGGTGTCtgcAGTGTCGTCTGC 1342..1368 Antisense M452
MP452s GCAGACGACACTgcaGACACCGCGCCA 1342..1368 Sense M452
MP453a CCATGGCGCGGTtgCAAAAGTGTCGTC 1345..1371 Antisense M453
MP453s GACGACACTTTTGcaACCGCGCCATGG 1345..1371 Sense M453
MP454a CACCCATGGCGCtGcGTCAAAAGTGTC 1348..1374 Antisense M454
MP454s GACACTTTTGACgCaGCGCCATGGGTG 1348..1374 Sense M454
MP455 GGGCACCCATGGtcCGGTGTCAAAAGT 1351..1377 Antisense M455
MP456 AGAGGGCACCCAcGcCGCGGTGTCAAA 1354..1380 Antisense M456
MP457 ACCAGAGGGCACtgcTGGCGCGGTGTC 1357..1383 Antisense M457
MP458a GAGACCAGAGGGtgCCCATGGCGCGGT 1360..1386 Antisense M458
MP458s ACCGCGCCATGGGcaCCCTCTGGTCTC 1360..1386 Sense M458
MP459a AAAGAGACCAGAtGcCACCCATGGCGC 1363..1389 Antisense M459
MP459s GCGCCATGGGTGgCaTCTGGTCTCTTT 1363..1389 Sense M459
MP460a GGCAAAGAGACCtGcGGGCACCCATGG 1366..1392 Antisense M460
MP460s CCATGGGTGCCCgCaGGTCTCTTTGCC 1366..1392 Sense M460
Tw cttcctttcgggctttgtta - (on pET3a) Antisense M452-60 39 outside primer
IDP1L AGACTGAGGCCTTTGTCC 80..97 Sense ID1-4, 59, outside primer
IDP1a CATTggtaccGTACGAGCAGAGAACAGT 298..315 Antisense ID1
IDP1s GTACggtaccAATGGCATAATTTCCTCT 370..387 Sense ID1
IDP2a AGTGggtaccCTTAATGGTGGAGAGCAG 394..411 Antisense ID2
IDP2s TAAGggtaccCACTACTTTGGGGGACCT 457..474 Sense ID2
IDP3a AAAGggtaccAAATTGACGGTTGGCAGA 544..561 Antisense ID3
IDP3s ATTTggtaccCTTTGCGTCAATGTGGAG 610..627 Sense ID3
IDP4a CAAAggtaccAATGCAGCTCCGGTCGGT 652..669 Antisense ID4
IDP4s CATTggtaccTTTGACCCCATCTACCCA 715..732 Sense ID4
IDP1R ATGACCGGGGCCCAGTTTG 900..918 Antisense ID1-4, 39, outside primer
IDP5L CAAACTGGGCCCCGGTCAT 900..918 Sense ID5-6, 59, outside primer
IDP5a GCACggtaccGATGTTGACTGGGACCCG 1021..1038 Antisense ID5
IDP5s CATCggtaccGTGCTCCTCCAATACAAA 1072..1089 Sense ID5
IDP6a TGTTggtaccACCCCCACTGTGGCGGAT 1105..1122 Antisense ID6
IDP6s GGGTggtaccAACATTGTGACGGCCTTC 1156..1173 Sense ID6
IDP5R AGCCAGCCGCGGTGCTCAA 1309..1327 Antisense ID 5-6, 39, outside primer
Note. In ‘‘Sequences’’ column: uppercase indicates the sequence in EBV DNase, while lowercase shows sequences other than DNase, such as
mutated, restriction enzyme sites or flanking sequences to stabilize the annealing reaction.
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retained 63 6 10% nuclease activity, while CD450, with
the C-terminal 21 residues deleted, lost nuclease activity.
To further define which residues in the region, amino
acids 451 to 460, were required for nuclease activity,
full-length EBV DNase molecules with single amino acid
substitutions were generated following site-directed mu-
tagenesis (see Materials and Methods). The amino acid
sequence of residues 451–460 is TFDTAPWVPS. Each
residue from amino acids 451 to 460 was replaced by
alanine, except for the alanine at residue 455, which
changed to glycine. The bacterially expressed proteins
and nuclease activities of these mutants relative to the
wild-type are shown in Fig. 1. The relative activities of
M451–460 to the wild-type activity are 99 6 10, 2 6 2,
92 6 5, 92 6 8, 78 6 8, 46 6 10, 118 6 6, 20 6 5, 92 6
5, and 118 6 5%, respectively. The data shown are the
mean values of at least three experiments. Mutations at
Phe452 (M452) and Val458 (M458) reduced the nuclease
activities drastically, especially Phe452. M458 retained
20% activity, whereas M452 lost 98% activity. Interest-
ingly, mutations at amino acid 457 (M457) and 460
(M460) enhanced the nuclease activities. These data
indicate that the C-terminus of EBV DNase contributes to
nuclease activity.
Deletion of conserved regions
Since mutations at the N- or C-terminus, such as
single amino acid substitutions and small deletions,
caused complete impairment of nuclease activity, we
tried to investigate the effect of mutations at internal
regions of the EBV DNase. Seven highly conserved re-
gions were predicted from amino acid sequence align-
ments of various herpesvirus DNases, as described un-
der Materials and Methods (data not shown). We chose
four of the seven conserved regions, and two less well
conserved regions as controls, for deletion mutation
studies. DNA of all six ID mutants was prepared using a
recombinant PCR method and detection of the proteins
expressed in bacteria is shown in Fig. 2. All ID mutants,
regardless of which region was absent, showed a
marked loss of nuclease activity (Fig. 2). These results
suggest that not only are highly conserved regions es-
sential for the nuclease activity of EBV DNase, but non-
conserved regions are required also. Taken together, an
intact, highly ordered structure seems to be important for
EBV DNase function.
DNA binding ability of DNase mutants
One possible reason that these DNase mutants lost
nuclease activity is through loss of ability to bind the
substrate DNA. To determine the abilities of these
mutants to bind DNA and to map the regions involved
in DNA binding, DNase mutant polypeptides were ex-
pressed using an in vitro IVT and labeled with [35S]me-
thionine. The IVT-expressed polypeptides were loaded
on ssDNA or dsDNA cellulose columns and the DNA
binding abilities were determined through the elution
profiles with NaCl step gradients. As shown in Fig. 3,
the IVT-expressed wild-type DNase bound efficiently
to dsDNA and ssDNA cellulose, and the protein could
be detected in the fraction eluted by 500 mM NaCl
(.20% to the amount of the starting material). The
FIG. 2. Expression and relative nuclease activities of internal dele-
tion mutants, ID1–ID6, of EBV DNase. The bacterially expressed pro-
teins of ID1–ID6 and pDNase 5 (WT) were detected by ECL Western
blot using monoclonal antibody 311H to EBV DNase (bottom panel).
The deleted regions of ID1 to ID6 are residues 106–123, 138–152,
188–203, 224–238, 347–357, and 375–385, respectively. Construction of
these mutants and calculation of the relative nuclease activity are
described under Materials and Methods.
FIG. 1. Protein expression and relative nuclease activities of C-
terminal deletion and substitution mutants of EBV DNase. Polypeptides
which were expressed in E. coli transformed with plasmids CD460,
CD450, M451–M460, pDNase5 (WT), or pET3a were analyzed by ECL
Western blot using monoclonal antibody 311H to EBV DNase (bottom
panel). Construction of these mutants and calculation of the relative
nuclease activity are described under Materials and Methods.
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elution profiles of ND48 and CD460 were similar to
that of wild-type (Fig. 3). Although ND48 and CD460
had nuclease activities reduced to about 20% (Lin et
al., 1994) and 37% (Fig. 1), respectively, their DNA
binding abilities were not affected. In contrast, CD450
lost its nuclease activity completely while retaining
FIG. 3. DNA binding by WT and mutants of EBV DNase. [35S]Methionine-labeled wild-type (WT) and mutant DNase polypeptides synthesized by IVT were applied
to dsDNA or ssDNA cellulose columns and eluted with NaCl step gradients. Eluted fractions were analyzed by 10% SDS–PAGE followed by autoradiography. Lane
1, starting material; lane 2, flow through (FL); lane 3, 100 mM NaCl eluant; lane 4, 200 mM NaCl eluant; lane 5, 300 mM NaCl eluant; lane 6, 400 mM NaCl eluant;
lane 7, 500 mM NaCl eluant. The relative polypeptide concentration of each fraction is indicated under the panel of eluted polypeptides.
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DNA binding activity, suggesting that changes other
than the loss of DNA binding might contribute to the
loss of nuclease activity for CD450.
The IVT-expressed polypetides from ND23–28 were
detected predominantly in the 300 mM NaCl fraction for
dsDNA–cellulose (20.4%) and in the 400 mM NaCl frac-
tion for ssDNA–cellulose (31.7%) (Fig. 3). ID2 was also
detected predominantly in the 300 mM NaCl fraction for
dsDNA–cellulose and ssDNA–cellulose (26.8 and 26.4%,
respectively) (Fig. 3). ND23–28 and ID2 did not lose DNA
binding activities completly but their nuclease activities
were abolished. The IVT-expressed polypeptides from
deletion mutants CD39, CD70, CD16, CD3, ND24, ID1,
ID3, ID4, ID5, and ID6 were detected predominantly in
the flow through or 100 mM NaCl fractions (.30%) (Fig.
3). Their abilities to bind to both dsDNA and ssDNA were
disrupted and all of nuclease activities were lost. In
addition, mutants M23, M27, M452, and M457 with single
residue substitution were chosen for further analysis.
M23 and M452 lost nuclease activities, but M27 and
M457 retained their nuclease activities (Lin et al., 1994;
Fig. 1). The DNA binding abilities of M23 and M452 were
similar to that of the wild-type (Fig. 3). Therefore, the loss
of the nuclease activities of M23 and M452 might be due
to other impairments, rather than the loss of DNA binding
activity. A summary of nuclease activities and DNA bind-
ing abilities of wild-type and mutants of EBV DNase is
shown in Fig. 4. Deletion of residues 1–8, 23–28, 138–
152, and 450–470 had less effect on DNA binding but
deletion of residues 7–61, 106–123, 188–203, 224–238,
347–357, 375–385, and 440–470 resulted in the loss of
DNA binding activity (Fig. 4). The results indicate that
DNA binding of EBV DNase requires a conformational
integrity contributed from peptides of different regions so
that an intact highly ordered structure of EBV DNase is
important for both nuclease and DNA binding activities.
FIG. 4. Summary of DNA binding and nuclease activities of WT and mutants of EBV DNase. Numbering refers to the amino acid residues of EBV
DNase. Translated regions of proteins are indicated by thin lines. The striped rectangles represent the deletion and shaded ovals represent the point
mutations. The affinity to bind DNA is indicated by the number of pluses. Five pluses (11111) represent high affinity, similar to the wild-type DNase,
eluted at 500 mM NaCl. Three pluses (111) indicate middle affinity, such as ID2, eluted at 300 mM NaCl. The minus (2) represents low affinity, such
as CD39, eluted at 100 mM NaCl or flow through. The nuclease activities less than 5% are indicated as a minus (2). At the bottom, black rectangles
indicate the deleted regions which resulted in the loss of DNA binding activity and open rectangles indicate the deleted regions which were
dispensable for DNA binding. The regions which have not been determined for their effect of DNA binding are represented by thin lines.
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DISCUSSION
Based on the data presented here and in a previous
study (Lin et al., 1994), mutational analysis of EBV DNase
revealed that deletions of the N- and C-termini and in-
ternal regions resulted in the loss of nuclease activity. At
the N-terminus, the deletion of residues 23–28 caused
the complete impairment of nuclease activity (Lin et al.,
1994). At the C-terminus, the deletion of the last 21 amino
acids inactivated the enzyme. Mutants with deletions of
the internal regions, including four conserved and two
nonconserved regions, did not show significantly detect-
able nuclease activity (,5%). Furthermore, some amino
acid substitutions at the extreme regions also caused
drastic reductions of nuclease activity. The four mutants
with low nuclease activity were M23 (Leu to Gly), M28
(Thr to Gly), M452 (Phe to Ala), and M458 (Val to Ala),
showing 2, 30, 2, and 20%, respectively, of the nuclease
activity of the wild-type enzyme. Mutations of the two
hydrophobic residues, Leu23 and Phe452, led to loss of
DNase activity. Since mutations in many regions of EBV
DNase from the N- to C-terminus resulted in the loss of
nuclease activity, an intact structure seemed to be re-
quired for EBV DNase function. Based on these data, it
was not possible to assign a role for these regions or
individual residues in nuclease activity. However, it has
been reported that hydrophobic residues in terminal re-
gions of DNase I (Liao, 1975) and ribonuclease A (Lin,
1970) were essential for the nuclease activity. Both
Leu256 of DNase I and Phe120 of ribonuclease A play a
role in stabilizing and maintaining the native conforma-
tion of the enzymes rather than participating in catalysis
and substrate binding (Suck et al., 1984). Leu23 and
Phe452 of EBV DNase may play a similar role. Since
substitutions of Leu23 and Phe452 in EBV DNase did not
affect the DNA binding ability (Fig. 3), neither seems to
be involved in substrate binding. Although these two
hydrophobic residues might not participate in catalysis
and substrate binding, they could hamper nuclease func-
tion due to disruption of functional enzyme structure.
EBV DNase utilizes both ssDNA and dsDNA as sub-
strates and digests ssDNA and dsDNA distributively and
processively, respectively (Lin et al., 1995). The EBV
DNase expressed in lymphoid cells or E. coli was eluted
from DNA cellulose at ;300 mM NaCl or KCl (Clough,
1979; Chen et al., 1993; Hwang et al., 1990). In this study,
ssDNA and dsDNA cellulose chromatography was used
to determine the DNA binding ability of each mutant
polypeptide. The wild-type EBV DNase expressed by IVT
bound efficiently to both ssDNA and dsDNA and was
eluted at 500 mM NaCl (Fig. 3). To compare the elution
profiles of wild-type and mutants, the DNA binding abil-
ities of the mutants were divided into three groups: high
affinity (similar to the wild-type; eluted at 400 to 500 mM
NaCl), intermediate affinity (eluted at 200 to 300 mM
NaCl), and low affinity (flow through or eluted in 100 mM
NaCl). It is reasonable to predict that mutants which
retain the nuclease activity will possess a similar DNA
binding ability to the wild-type. Mutants ND48, CD460,
M27, and M457, which retained their nuclease activities,
belonged to the high affinity group and possessed wild-
type DNA binding ability. In the high affinity group, mu-
tants CD450, M23, and M452 retained wild-type DNA
binding abilities but lacked significant nuclease activity.
The deficiencies in this kind of mutant might be due to
the loss of catalytic conformation rather than ability to
bind to DNA. Mutants in the intermediate affinity group,
including ND23–28 and ID2, showed a reduction in DNA
binding. Therefore, some regions (residues 23–28, 138–
152, and 450–460) and residues (Leu23 and Phe452) of
EBV DNase appeared to be dispensable for DNA binding
but required for nuclease activity. These regions and
residues may play roles in stabilizing and maintaining
the native conformation of the enzyme. In the low-affinity
group, mutants including CD39, CD70, CD69, CD16, CD3,
ND24, and ID1-6 (but not ID2) lost their ability to bind to
DNA. Since these mutants could not bind to DNA, their
nuclease activities were abolished as expected. Based
on these data, DNA binding sites of EBV DNase were not
located at a single local region but comprised of resi-
dues of many different regions.
Mutagenesis studies have increased our understand-
ing of relationship between structure and function of EBV
DNase. However, several aspects of EBV DNase remain
poorly defined, including the protein domains responsi-
ble for binding divalent cations, interaction with other
EBV proteins such as EA-D, DNA polymerase, and mDBP
(Daibata and Sairenji, 1993; Lin et al., 1995), and nuclear
localization. The biological function of EBV DNase also
remains unclear. Because of the similarities among her-
pesvirus DNases, this group of enzymes may play a
similar role in the viral life cycle. In HSV-1, two major
defects in DNase null mutant were the loss of ability to
process viral DNA genomes correctly and the failure of
DNA-containing capsids to migrate into the cytoplasm
(Martinez et al., 1996; Shao et al., 1993), suggesting that
herpesvirus DNases may function at some steps of virus
maturation. Further analysis of functional domains of
EBV DNase should provide valuable information on cat-




pDNase5, a cDNA clone from P3HR1 cells, encodes the
full-length (470 amino acids) wild-type EBV DNase sub-
cloned into pET3a (Lin et al., 1994). The mutants in this
study were derived from pDNase5 by PCR and subcloning
strategies. Construction of mutated EBV DNase derivatives,
including ND48, CD39, CD70, CD16, CD3, ND23–28, ND24,
M23, and M27, was described previously (Lin et al., 1994).
11NUCLEASE AND DNA BINDING OF EBV DNase
CD460, CD450, M451, M455, M456, and M457 were gener-
ated using a Muta-Gene M13 in vitro mutagenesis kit (Bio-
Rad), following the manufacturer’s instructions. The oligo-
nucleotide primers for mutagenesis are shown in Table 1.
CD460 and CD450, to which a stop codon, TAG, was intro-
duced at codons 460 and 450, were deleted of the carboxyl
terminal 11 and 21 amino acids of EBV DNase, respectively.
M451, M456, and M457 were generated through mutation
by single amino acid substitutions with alanine at amino
acids 451, 456, and 457, respectively. M455 had a substitu-
tion of glycine for alanine at amino acid 455. M452, M453,
M454, M458, M459, M460, and ID1-ID6 were constructed
using recombinant PCR and the oligonucleotide primers
shown in Table 1. Each clone was generated by two con-
secutive PCR reactions and the corresponding regions of
pDNase5 were replaced with the recombinant PCR prod-
uct. For example, in the construction of ID1 (internal dele-
tion 1), the two primary PCR fragments of 228 and 540 bp
were amplified using primer pairs IDP1L, IDP1a and IDP1s,
IDP1R, respectively. The two primary PCR fragments were
mixed and annealed through the sequences of the junction
region shared by the inside primers, IDP1a and IDP1s,
which were identical in the last 10 nucleotides (Table 1).
The second PCR reaction was subsequently carried out by
mixing 10 ng of each primary PCR fragment as template
DNA, along with IDP1L and IDP1R as outside primers. A
recombinant PCR product of 768 bp was amplified. After
treatment with StuI and ApaI, the PCR amplified fragment
was used to replace the StuI–ApaI region of pDNase5. The
resulting plasmid, ID1, was further confirmed by the pres-
ence of a KpnI site (an enzyme site present only in the
recombinant PCR fragment). Similarly, the other mutants
were generated by the same procedures using the primers
in Table 1. M452, M453, M454, M458, M459, and M460
were obtained by single amino acid substitutions with ala-
nine at amino acids 452, 453, 454, 458, 459 and 460, re-
spectively. The mutants with single amino acid substitu-
tions were confirmed by dideoxy DNA sequencing. The
deleted regions of ID1–ID6 were replaced by insertion of a
KpnI linker (GGTACC), translated into glycine and threonine.
Alignments of amino acid sequences of herpesvirus
DNases
Sequence alignments were performed using the Wis-
consin GCG package (version 8), which is a comprehen-
sive computing resource operating in a VAX environment.
Amino acid sequences of DNases from HHV6, BHV,
HSV1, HSV2, and SHV were derived from their corre-
sponding nucleotide sequences using the TRANSLATE
program. Amino acid sequences of other herpesvirus
DNases were obtained directly from the protein bank.
Accession numbers for each sequence in GenBank
were: HSV1 (herpes simplex virus type 1), P04294; HSV2
(herpes simplex virus type 2), M11854; EHV1 (equine
herpesvirus type 1), U20824; EHV2 (equine herpesvirus
type 2), U25056; BHV (bovine herpesvirus), Z48053; VZV
(Varicella zoster virus), P09253; SHV (suid herpesvirus),
U25056; B95-8 (Epstein-Barr virus B95-8 strain), P03217;
HVS (herpesvirus saimiri), Q01013; HCMV (human cyto-
megalovirus), P16789; and HHV6 (human herpesvirus 6),
L14772. Multiple sequences alignment was performed
by PILEUP program and represented by PRETTY of GCG.
Expression of the DNase protein in Escherichia coli
and assay of nuclease activity
Expression of pDNase5 and its mutated derivatives
was carried out as described previously (Lin et al., 1994).
Briefly, a 2-ml culture of E. coli BL21(DE3) pLysS harbor-
ing a particular plasmid was grown to log phase (OD600
5 0.4–0.6) and induced for 2 h with 1 mM IPTG. Cells
were harvested and lysed with 250 ml of 50 mM Tris–HCl
(pH 8.0), 50 mM NaCl, 1 mM DTT, and 10% glycerol. After
sonication, 5 ml of prepared lysate at various dilutions
was assayed for nuclease activity (Chen et al., 1982). The
relative nuclease activity was normalized with the DNase
protein concentration. The nuclease activity of each
clone minus that of cells harboring pET3a left the net
nuclease activity. The specific nuclease activity was cal-
culated by dividing the net activity of each clone by the
intensity of each expressed protein in enhanced chemi-
luminescence (ECL) Western blot analysis, which were
quantitated by scanning with a densitometer (UltroScan
XL; Pharmacia). The relative nuclease activity is the spe-
cific nuclease activity of each clone divided by that of
pDNase5.
ECL Western blot analysis
The prepared crude bacterial lysates were separated
by 10% sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (SDS–PAGE) and transferred to Hybond C
supermembrane (Amersham). The blot was incubated
with blocking buffer (10 mM Tris–HCl, pH 8.0, 0.9% NaCl,
and 4% skim milk) for 1 h and reacted with anti-DNase
monoclonal antibody 311H (Tsai et al., 1997) for 1 h at
room temperature. After washing three times with wash-
ing buffer (10 mM Tris–HCl, pH 7.4, 0.9% NaCl, 0.2%
Tween 20), the blot was incubated with horseradish
peroxidase-labeled goat anti-mouse IgG (Amersham) di-
luted 1:2500 with blocking buffer for 1 h at room temper-
ature. After incubation, the blot was washed three times
in washing buffer and once with water and then devel-
oped with freshly prepared substrate according to the
manufacturer’s instructions (ECL Western blotting, Amer-
sham). The luminescence was detected by a short ex-
posure to X-ray film. The relative concentration of each
polypeptide of EBV DNase and its mutants was deter-
mined by scanning with a densitometer (UltroScan XL;
Pharmacia).
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Expression of the DNase protein by IVT and assay
of DNA binding activity
Using a TNT T7-coupled reticulocyte lysate system
(Promega), DNA templates of pDNase5 and its mutants
were transcribed with T7 RNA polymerase and trans-
lated in a rabbit reticulocyte lysate. Each 0.25 mg of CsCl
density gradient-purified plasmid DNA was used as an
IVT template in a final volume of 12.5 ml. The IVT-ex-
pressed polypeptides were radiolabeled in the reaction
mixture containing [35S]methionine. After 90 min of in
vitro translation at 30°C, the [35S]methionine-labeled
polypeptides were diluted 1:10 in buffer A (50 mM Tris–
HCl, pH 8.0, 1 mM DTT, 1 mM PMSF, 10% glycerol)
containing 100 mg RNase A. An aliquot (12.5 ml) was
retained as starting material and the remainder was
applied to a 200-ml bed volume of dsDNA or ssDNA
cellulose (Sigma) in a Bio-Spin column (Bio-Rad) equili-
brated in the buffer A. The column was washed with 300
ml of buffer A and then eluted with 400-ml step gradients
of 100, 200, 300, 400, and 500 mM NaCl in buffer A. Five
ml of starting material and 20 ml of eluates were mixed
with SDS–PAGE sample buffer and analyzed by 10%
SDS–PAGE and fluorography. The relative concentration
of eluted polypeptides in each fraction was determined
by scanning with a densitometer.
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